Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal
As has been proven time and again, “gut feeling” and wishful thinking have never been shown to replace controlled clinical testing.
Arthur Caplan
-
Read more: Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal -
Read more: The National Anti-Vaccine Movement Heads to Hartford to Intimidate CT Legislators The National Anti-Vaccine Movement Heads to Hartford to Intimidate CT Legislators
Legislators should show the out-of-state anti-vaccine movement that intimidation doesn’t work here.
-
Read more: Bioethicist Art Caplan: A New Mind-Body Problem Bioethicist Art Caplan: A New Mind-Body Problem
A new piece by Bill of Health contributor Arthur Caplan, with Lisa Kearns, in The Hastings Center Bioethics Forum: Not since Rene Descartes gazed from his garret window in early 17th-century Paris and wondered whether those were men or hats and coats covering “automatic machines” he saw roaming the streets has the issue of personal…
-
Read more: NYULMC: Compassionate Use Could Impact Long-Term Medical Benefits NYULMC: Compassionate Use Could Impact Long-Term Medical Benefits
A new working group at the NYU Langone Medical Center has issued preliminary findings from their studies on the research ethics of compassionate use. Among their findings include: Biotechnology companies have no legal or regulatory obligation to provide access to unapproved treatments on the grounds of compassionate use. Some companies allow access under the guidance of well…
-
Read more: Blogger Twitter Round-Up Blogger Twitter Round-Up
By Parker Davis This week’s twitter round up features a variety of topics from our contributors, from the chemical imbalance theory to infant mortality rates and IVF conception rates. Frank Pasquale tweeted an article from The Star about the shift of the chemical imbalance theory related to mental illness from an agreed upon medical principle…
-
Read more: Twitter Round-Up 2/12 Twitter Round-Up 2/12
This week’s twitter round up features a variety of topics from our contributors from the hunger crisis in America to the contraceptive mandate and the Lancet/Oslo Commission on Global Governance for Health. Frank Pasquale tweeted an article from MSNBC about the millions of residents of New York suffering from hunger and the American hunger crisis…
-
Read more: Defining mental illnesses: can values and objectivity get along? Defining mental illnesses: can values and objectivity get along?
Petrie-Flom Student Fellow Michael J. Young has co-authored a new article with Dominic Sisti (Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania) and Bill of Health contributor Art Caplan (Division of Medical Ethics, NYU Langone Medical Center) in BMC Psychiatry on the ethical implications of efforts to base mental health diagnoses in biological causes….
-
Read more: Twitter Round-Up 11/20 Twitter Round-Up 11/20
In this Twitter round-up, many of our contributors shared news about end-of-life care and decision making. Some also continued to share their own thoughts, and those of others, about the Affordable Care Act. Amitabh Chandra posted a NY Times article entitled “How Doctors Die.” The piece discusses some of the contrasts, which some might regard…
-
Read more: Twitter Round-up 10/22 Twitter Round-up 10/22
By Sara Providence This week, our contributors tweeted quite a bit about the Affordable Care Act, but also about vaccination, the cost of extending life, and the budgetary impact of preventive health policy. Amitabh Chandra (@AmitabhChandra2) tweeted the piece “The Cost of Living,” a New York Magazine article about the dilemma posed by very expensive…
-
Read more: New Support for the SUPPORT Study in NEJM New Support for the SUPPORT Study in NEJM
The New England Journal of Medicine has two new commentaries out on the SUPPORT study and arguing that OHRP has things all wrong – in a dangerous way. From the editors: “[OHRP’s] response is disappointing, because it does not take into account either the extent of clinical equipoise at the time the study was initiated…